Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
BMI 35.0 to 39.9 (class II obesity)
Eccentric treatment for patellar tendinopathy: a prospective randomised short-term pilot study of two rehabilitation protocols
If additional glycaemic control is needed, the dose may be increased to 1 mg weekly and up to a maximum of 2 mg weekly
Lifestyle modifications not only enhance the effect of the medication but also prepare patients to sustain results even after treatment ends
Self-medicating or adjusting doses independently can lead to adverse effects, inadequate disease control, or dangerous drug interactions
US$ 20.70
US$ 27.09
.webp)
US$ 21.09
US$ 27.89
